TOBI Podhaler : H/C/PSUSA/00009315/202406 - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Source
European Medicines Agency
Additional Information
medication.label.product_type
scientific-conclusion
medication.label.permit_number
EMA/164174/2025
medication.label.permit_validity
First published: 2025-05-13T16:21:01Z
Documents
Related Medications
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
AI Voice
Listen to the article content live